| 
Cervical
cancer
prevention
Impending preventive
vaccines and
currently available DNA tests mean
major changes to existing
practices
Eduardo L. Franco, MPH, DrPH,
Marie-Hélène Mayrand, MD, MSc, FRCSC and Helen Trottier, MSc, PhD
Can
foods combat cancer?
What epidemiological, laboratory,
animal and
clinical studies show
Richard Béliveau,
PhD and Denis Gingras, PhD
Medical
decision making
What the research shows about
patient preferences
and the effects
of participation
Lesley F.
Degner, RN, PhD
Canadian
clinical trials in
lung cancer
An insider’s view of the growing
role
of the NCIC-CTG
Glenwood Goss, MD, FRCPC
and Nevin Murray, MD,
FRCPC
Funded by
an educational grant from AstraZeneca
Canada Inc. Cover
photo: Cervical cancer cell • s.gschmeissner/spl/publiphoto |
Essential
reading: research updates and commentaries
Review of important clinical trial data
recently presented at the 42nd Annual
Meeting of the American Society of
Clinical Oncology
With commentaries by Susan
Dent, MD, FRCPC, Debjani Grenier, MD, FRCPC, Lyly Le, MD, CM, FRCPC,
Joseph Ragaz, MD, FRCPC and Eric Winquist, MD, FRCPC
RENAL CANCER
COLORECTAL CANCER
BREAST CANCER:
neoadjuvant chemotherapy,
chemotherapy-related cardiotoxicity,
switching hormonal therapies,
hormonal therapies and bone health,
biological therapies and EGFR and
biomarkers predicting chemotherapy effect
Professional
meetings roster
Your calendar dates for essential
conferences
and symposia
New
drugs and indications
A review of recent cancer therapy
approvals
in Canada and the U.S.
|
